Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267102-e0267102
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Binding Antibodies Responses to SARS-COV-2 Infection in Hospitalized Patients and Vaccinated Subjects: A Longitudinal Prospective Observational Study
Mohammed Alshahrani, Razan Aldahhan, Nabela Calamata Macadato, et al.
Saudi Journal of Medicine and Medical Sciences (2025) Vol. 13, Iss. 1, pp. 39-46
Open Access
Determinants and dynamics of the seroprevalence of anti‐SARS‐CoV‐2 antibodies in Poland
Justyna Adamczuk, Karol Kamiński, Sebastian Sołomacha, et al.
Advances in Medical Sciences (2025)
Closed Access
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Lucia Spicuzza, Davide Campagna, Chiara Di Maria, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 375-401
Open Access | Times Cited: 14
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Kimia Sobhani, Susan Cheng, Raquel A. Binder, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1644-1644
Open Access | Times Cited: 11
One Is the Loneliest N: An Autobiographical Report of Long COVID
Angela M. O’Connor
(2024)
Open Access | Times Cited: 2
Anti-SARS-CoV-2 Antibody Testing: Role and Indications
Sylvia Mink, Peter Fraunberger
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7575-7575
Open Access | Times Cited: 7
Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes
Piotr Rzymski, Jacek Niedziela, Barbara Poniedziałek, et al.
Virology (2024) Vol. 596, pp. 110118-110118
Open Access | Times Cited: 2
Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
Karin Taffertshofer, Mirko Walter, Peter Mackeben, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis
Qiuying Zhang, Lirui Jiao, Qiushi Chen, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment
Sitthichai Kanokudom, Kittiyod Poovorawan, Pornjarim Nilyanimit, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313771-e0313771
Open Access | Times Cited: 1
Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
Clara Schnizer, Nico Andreas, Wolfgang Vivas, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 4
Seroprevalence of anti-SARS-CoV-2 antibodies and associated factors among household contacts of COVID-19 confirmed cases in Bangkok, Thailand
Kamolthip Atsawawaranunt, Khammakorn Thiangthangthum, Somrak Sirikhetkon, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16501-e16501
Open Access | Times Cited: 4
SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet’s owners and with protection against subsequent SARS-CoV-2 infection?
Hannah Murphy, Shania Sanchez, Shamim Ahmed, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 1216-1220
Open Access | Times Cited: 5
Mediators profile in COVID-19 convalescence: an approach in individuals from amazon
Alexander Leonardo Silva-Junior, Lucas Silva de Oliveira, Stephanny Dias, et al.
Research Square (Research Square) (2024)
Open Access
Dynamic Modeling of Antibody Repertoire Reshaping in Response to Viral Infections
Zhaobin Xu, Junxiao Xu, Hongmei Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations
Gemma Pons-Tomàs, Rosa Pino, Aleix Soler-García, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 622-622
Open Access
Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
Wathusiri Khongsiri, Prapassorn Poolchanuan, Adul Dulsuk, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Dynamic modeling of antibody repertoire reshaping in response to viral infections
Zhaobin Xu, Qingzhi Peng, Junxiao Xu, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109475-109475
Closed Access
The Protective Effect of Serum Antibodies in Preventing SARS-CoV-2 Virus Entry Into Cardiac Muscle
M. Kessler, Tomáš Vojtíšek, Tomáš Zeman, et al.
Physiological Research (2024), Iss. Suppl. 3, pp. S715-S725
Open Access
Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria
Heike Rebholz, Ralf J. Braun, Titas Saha, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271382-e0271382
Open Access | Times Cited: 3
Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
Nesrin Gareayaghi, Mehmet Demırci, Doğukan Özbey, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1672-1672
Open Access | Times Cited: 3
Comparative ELISA Detection of SARS-COV-2 Monoclonal Antibodies in Patients` Serum, Saliva, and Nasal Fluid in Iraq
Ghaith Mohammed, Ghada Abdul–Rahman
Israa University Journal for Applied Science (2023) Vol. 6, Iss. 2, pp. 15-41
Open Access | Times Cited: 1
Design and Performance Characteristics of the Elecsys Anti-SARS-CoV-2 S assay
Karin Taffertshofer, Mirko Walter, Peter Mackeben, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top